A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Chemoprevention is the use of certain drugs to keep cancer from forming. The use of
atorvastatin (Lipitor) may prevent breast cancer. This randomized phase I trial is studying
the best dose of atorvastatin in preventing breast cancer in women at increased risk for
breast cancer.